OR WAIT null SECS
June 25, 2018
Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
June 13, 2018
Cambrex expands its generic API research and development capabilities at its Milan, Italy site.
June 06, 2018
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
June 02, 2018
From separation systems to reactor technology, new tools are increasing the feasibility of continuous API production.
June 01, 2018
Cambrex invests $5 million in new laboratory expansion at its Karlskoga, Sweden facility.
May 16, 2018
Cambrex Corporation has announced facility, equipment, and instrument upgrades at its High Point, NC facility and updated progress on expansions in Cedar City, IA.
April 24, 2018
Porton will use biocatalyst technologies from Codexis to accelerate API development for clients.
April 20, 2018
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
April 16, 2018
Kemiex trading network is designed to increase safety in the sourcing of APIs and additives.
April 02, 2018
Particle engineering using jet milling or spray drying can be used to obtain appropriate particle characteristics for inhalation drug products.